Suppressors of cytokine signaling abrogate diabetic nephropathy.
about
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadeThe role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal diseasePresent and future in the treatment of diabetic kidney diseaseDiabetic Kidney Disease: Pathophysiology and Therapeutic Targets2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsDiscovering hidden relationships between renal diseases and regulated genes through 3D network visualizations.SOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cellsDJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial CellsRole of transcription factor acetylation in diabetic kidney disease.IL-18 induces profibrotic renal tubular cell injury via STAT3 activation.The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.Inflammation in diabetic kidney diseaseEffects of 1,25-(OH)(2)D (3) on the expressions of vitamin D receptor, STAT5 and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes patients and diabetic nephropathy patients with uremia.New targets for treatment of diabetic nephropathy: what we have learned from animal models.Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissueAnti-inflammatory effect of 1,25-dihydroxyvitamin D3 is associated with crosstalk between signal transducer and activator of transcription 5 and the vitamin D receptor in human monocytesAbsence of nicotinic acetylcholine receptor α7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model.Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.Adipose-Derived Mesenchymal Stem Cells Transplantation Alleviates Renal Injury in Streptozotocin-Induced Diabetic NephropathyTranscriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulationTreatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trialmiR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signalingMacrophage-derived IL-6 contributes to ANG II-mediated angiotensinogen stimulation in renal proximal tubular cells.Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.Activation of PI3K in response to high glucose leads to regulation of SOCS-3 and STAT1/3 signals and induction of glomerular mesangial extracellular matrix formation.Antifibrotic treatment and other new strategies for improving renal outcomesTargeting inflammation in cardiovascular diseases. still a neglected field?Chromatin modifications associated with diabetes.SOCS and diabetes--ups and downs of a turbulent relationship.Therapeutic approaches to diabetic nephropathy--beyond the RAS.JAK inhibition and progressive kidney disease.Key pathways in renal disease progression of experimental diabetes.Therapies on the Horizon for Diabetic Kidney Disease.Targeting inflammation in diabetic kidney disease: early clinical trials.Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation.JAK inhibition in the treatment of diabetic kidney disease.
P2860
Q26799443-C56386A4-BDD4-464D-905A-AD50A3625902Q26825424-EBBAEA20-7BDF-45FB-8BC0-16124F73DFFFQ26864133-FCA38C5E-71C9-43B0-B586-19B22449B259Q28086840-BAE0F7A4-0BB9-40BC-8645-470B6247AF57Q30239808-D13F4E26-3DE9-4621-8443-D4E1D1541906Q33744411-BBB02DD6-B4D9-49BC-8A80-BDB6B1C6AA5EQ33744838-D58C949E-E821-4CB0-9FE4-E2396D34C165Q33786872-68E29CA8-6B27-4842-8B22-AA8844E61F32Q33789303-1B69C974-BEFD-4101-80C7-2E2F073E18BBQ33816800-C13E1A7E-656D-4D33-B498-D9D1F39B27E8Q33974670-63431E94-064D-45CB-AC33-3A2E9DE76DB9Q34023543-1186D1F5-6ECB-46A4-B689-CF1247E253DCQ34155747-E48A58CB-488D-48B9-9745-5D47EB53A641Q34498964-0BCAD22B-6402-4D24-B6CE-3686EFFDEEADQ34754640-53758112-3971-4C18-BBC9-9D6137705E5CQ35681434-2678B450-5DA2-42EA-9E4B-37538ECB19FEQ35879006-CA7BAD7F-0567-42E5-A759-7C2C43B9CF4CQ35913007-1261910F-090A-4482-89C5-D4ADE82054E7Q36477207-1A0C3E09-75B6-4D2F-ABA1-D6942BCDE78FQ36742574-B507D706-03A6-4EAF-AD13-18B624FCC7DFQ36889267-C68683D0-2161-4D52-9DB8-D78CDB9731F0Q36895449-BEC77392-DCA5-4EEF-8D26-346DC871A889Q36897652-1BDAA4FE-A20D-4224-BD33-5ACB6DF3A16CQ36977367-AC1E058D-A51C-41BF-9ADD-598F0DD91BF7Q37129456-50419193-E715-42D3-B7AA-4331F6C871F0Q37172306-64FED22A-7508-4CE5-B264-5133DA345B59Q37253944-F50447F3-5188-4D40-8A2D-DE1D64A71483Q37515836-D8AFAFDE-671B-4A82-9880-2A02C9E6932EQ37725543-B7EADE30-EE06-49D4-8B2B-7E6316BA581FQ37887401-88519A27-CC87-47F1-B63F-0A5B9313CEBFQ37925018-98E08DAF-98E5-4982-BB6B-CE280CF022B2Q38013734-58689019-9BF7-4921-AED1-8EA5D339FB4BQ38075516-AE586337-EE93-4D9E-AF14-0636F4F31FB9Q38209811-1C97DCEE-2B61-4BC7-8D93-E549A0BA65B1Q38270332-CEDF20CE-BE15-4B43-B48C-745F5B79CE0CQ38553926-0C89BBD2-2D66-4973-8988-C32A66085A19Q38605099-C6246135-9512-4FCD-9C3C-6178D1667D40Q38857166-DD5DF997-6E6E-48A0-938C-174956A009F3Q38868643-F10D0641-C0E1-4AEB-8C9A-664AD2139A14Q38873515-5373490E-9FA7-4339-BE2F-B642E28787E6
P2860
Suppressors of cytokine signaling abrogate diabetic nephropathy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Suppressors of cytokine signaling abrogate diabetic nephropathy.
@en
Suppressors of cytokine signaling abrogate diabetic nephropathy.
@nl
type
label
Suppressors of cytokine signaling abrogate diabetic nephropathy.
@en
Suppressors of cytokine signaling abrogate diabetic nephropathy.
@nl
prefLabel
Suppressors of cytokine signaling abrogate diabetic nephropathy.
@en
Suppressors of cytokine signaling abrogate diabetic nephropathy.
@nl
P2093
P2860
P356
P1476
Suppressors of cytokine signaling abrogate diabetic nephropathy.
@en
P2093
Beñat Mallavia
Carmen Gomez-Guerrero
Claudio Flores
Guadalupe Ortiz-Muñoz
Jesus Egido
Julia Blanco
Oscar Lopez-Franco
Sergio Mezzano
Virginia Lopez-Parra
P2860
P304
P356
10.1681/ASN.2009060625
P577
2010-02-25T00:00:00Z